TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.
about
Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis.Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network
P2860
TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@en
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@nl
type
label
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@en
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@nl
prefLabel
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@en
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@nl
P2093
P2860
P1433
P1476
TP53 mutation-mediated genomic ...... in epithelial ovarian cancer.
@en
P2093
Meiying Zhang
Wenjing Wang
Xiangjun Sun
Yanying Shen
P2860
P2888
P356
10.1186/S13000-017-0605-8
P577
2017-02-02T00:00:00Z
P6179
1083403220